Drs. Susan O'Brien and Catherine Wu Presented ... - CLL Support

CLL Support

23,324 members40,026 posts

Drs. Susan O'Brien and Catherine Wu Presented the Binet-Rai Medal at 20th International Workshop on Chronic Lymphocytic Leukemia

Kwenda profile image
5 Replies

Two doctors who have spent many many hours helping the CLL community.

I FEEL SURE THAT WE ALL EXPRESS OUR MANY THANKS.

THIS IS AN AWARD THAT IS WELL DESERVED.

During this past weekend's 20th biennial International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Susan M. O'Brien, MD, and Catherine J. Wu, MD, were awarded the Binet-Rai Medal.

Since 1999, the iwCLL has presented the Binet-Rai Medal every two years to individuals and teams who help shape and enhance scientific understanding of CLL through important research and contributions.

Kanti Rai, MD, one of the two original recipients for whom the Medal was subsequently named, had the honor of presenting this year's awards to Drs. O'Brien and Wu:

"Dr. Susan O'Brien is an internationally recognized leader in the research and treatment of therapies for patients with both chronic and acute leukemias, and is a pioneer of several important therapies now regarded as the standard of care for CLL.

Dr. Catherine Wu is an internationally recognized expert in the biology and treatment of lymphoid malignancies, with a primary focus on CLL. This work has culminated in ongoing clinical trials where genomic information is being used to design a personalized vaccine to test the impact on generation of an immune response and anti-tumor activity."

More at :- prnewswire.com/news-release...

Dick

Written by
Kwenda profile image
Kwenda
To view profiles and participate in discussions please or .
Read more about...
5 Replies
Newdawn profile image
NewdawnAdministrator

Well deserved indeed! 🏆

Newdawn

cajunjeff profile image
cajunjeff

Thanks for posting Kwenda. I like to read some selected abstract summaries of these conferences, but all the iwcll website for the meeting provides is titles, unless I just dont know where to click. Does anyone know where the actual papers or abstracts are published?

CLLerinOz profile image
CLLerinOzAdministrator in reply tocajunjeff

Hi Jeff

I've just added a reply to an earlier post about the iwCLL 2023 conference to provide a link to the full abstracts in Leukemia and Lymphoma's online journal."

healthunlocked.com/cllsuppo...

There's a lot of reading!

CLLerinOz

Peggy4 profile image
Peggy4

Very well deserved indeed!🏆

Peggy

chronicguy profile image
chronicguy

Dr O'Brien has been my CLL specialist for 5 years. She is excellent. CONGRATULATIONS DR OBRIEN!

Not what you're looking for?

You may also like...

Vaccines, Ibrutinib toxicity,Dr. Rai on a cure, Dr Ghia on TP563 testing and ERIC

I warned that our website's pages would be busy through the end of the year. I tried to synthesize...
bkoffman profile image
CLL CURE Hero

Determining if you'll never need treatment. It is feasible and safe to stop specialized follow-up of asymptomatic lower risk CLL?

Regular readers will have often heard that around 30% of those diagnosed with CLL never need...
AussieNeil profile image
Partner

Bone marrow looking for MRD getting a surprise in the blood test, plus Dr. Kipps on fixed duration front line therapy

I just blogged on how my recent blood work and bone marrow biopsy looking for MRD status could have...
bkoffman profile image
CLL CURE Hero

News about V+O and Acalabrutinib from EHA

Hi, The future of CLL therapy we believe will include fixed duration treatments of non-chemo drugs....
bkoffman profile image
CLL CURE Hero

White Paper recommends steps to improve the care and support of people with Chronic Lymphocytic Leukemia who face immune challenges

". . . despite advances in therapy, infection remains a major risk in CLL and is a key challenge...
CLLerinOz profile image
Administrator